Cardiff Oncology Inc. buy quelbe60
Start price
20.02.22
/
50%
€2.52
Target price
20.02.23
-
Performance (%)
-16.67%
End price
05.03.22
€2.10
Summary
This prediction ended on 05.03.22 with a price of €2.10. The price of Cardiff Oncology Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.67%. quelbe60 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | -8.016% | -8.016% | 56.713% | 56.713% |
iShares Core DAX® | 0.349% | 1.049% | 31.190% | 80.131% |
iShares Nasdaq 100 | -0.123% | 2.919% | 13.472% | 62.641% |
iShares Nikkei 225® | 4.212% | -0.666% | 5.130% | 18.929% |
iShares S&P 500 | 0.479% | 3.318% | 9.358% | 43.416% |
Comments by quelbe60 for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Buy beendet